Quantitative Assessment of Expression of Lactate Dehydrogenase and its Isoforms 3 and 4 may Serve as Useful Indicators of Progression of Gallbladder Cancer: A Pilot Study
- 101 Downloads
We have studied the expression of lactate dehydrogenase and its isoforms in gall bladder cancer, cholelithiasis and chronic cholecystitis. Quantitative and qualitative assays of lactate dehydrogenase and its various isoforms were carried out in the blood sera of patients and healthy controls along with parallel estimation of various liver function test enzymes. Statistical analysis was done using the software Graph Pad Prism. Significantly high expression of lactate dehydrogenase along with alkaline phosphatase and total bilirubin (P ≤ 0.05) was observed in all the three clinical conditions as compared to controls. LDH showed an increasing trend from stage I to stage IV of GBC indicating a significant positive association with the disease progression. The levels of LDH 3 and 4 isoforms appeared significantly more elevated in GBC than cholelithiasis or chronic cholecystitis. We suggest that a careful estimation of total LDH and its isoforms 3 and 4 alone or along with alkaline phosphatase and total bilirubin during different clinical stages, like chronic cholecystitis, cholelithiasis and GBC, may prove to be a potentially useful biomarker in the prognostic management of gall bladder diseases, specifically GBC.
KeywordsGallbladder cancer Lactate dehydrogenase Cholelithiasis Chronic cholecystitis
We acknowledge financial support of Department of Biotechnology, Government of India to Centre for Genomics, Jiwaji University. We also acknowledge the help extended by Dr. Manisha Kakkar during sample collection. MAB is a recipient of Senior Research Fellowship from Indian Council of Medical Research. TDS is grateful to JU for research fellowship.
- 1.De Stoll M. Rationis mendendi, in nosocomio practico vendobonensi, part-I lugaumi batavanum. In: Haak et. Socios. et. A et. J Honkoop. Lugduni Batavorum: Amstelaedami; 1788.Google Scholar
- 2.Goldin RD, Roa JC. Gallbladder cancer: a morphological and molecular update. Histopathol. 2009. doi: 10.1111/j.1365-2559.2008.03192.x.
- 3.Barbhuiya MA, Singh TD, Gupta S, Shrivastav BR, Tiwari PK. Incidence of gall bladder cancer in rural and semi urban population of north-central India. A first insight. Internet J Epidemiol. 2009;7:2–25.Google Scholar
- 5.Holbrook JJ, Liljas A, Steindel SJ, Rossman MG. Lactate dehydrogenase. In: The enzyme Boyer PD. Vol. XI, 3rd ed. New York: Academic Press; 1975. p. 191–292.Google Scholar
- 8.Sevince E, Sari R, Fadillioglu E. The utility of lactate dehydrogenase isoenzyme pattern in the diagnostic evaluation of malignant and non-malignant ascites. J Natl Med Assoc. 2005;97:79–84.Google Scholar
- 11.Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL. Lactate dehydrogenase 5 expression in operable colorectal cancer: Strong association with survival and activated vascular endothelial growth factor pathway-a report of the Tumour Angiogenesis Research Group. J Clin Oncol. 2006;24:4301–8.PubMedCrossRefGoogle Scholar
- 13.Pravonen T, Liippo K, Aronen H, Kiistala U. Lactate dehydrogenase creatine kinase and their isoenzymes in pleural effusions. Clin Chem. 1991;37:1909–12.Google Scholar
- 22.Malloy TH, Evelyn KA. The determination of bilirubin with the photoelectric colorimeter. J Biol Chem. 1937;119:481–90.Google Scholar
- 23.Graph pad prism5. San Diego, California, USA. www.graphpad.com.